Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 22, Issue 3, 2016, Pages 449-455

  Arora, Mukta ^a   Cutler, Corey S ^b   Jagasia, Madan H ^c   Pidala, Joseph ^d   Chai, Xiaoyu ^e   Martin, Paul J ^e   Flowers, Mary E D ^e   Inamoto, Yoshihiro ^f   Chen, George L ^g   Wood, William A ^h   Khera, Nandita ⁱ   Palmer, Jeanne ⁱ   Duong, Hien ^j   Arai, Sally ^k   Mayer, Sebastian ^l   Pusic, Iskra ^m   Lee, Stephanie J ^e  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e USA   (United States)

^f NATIONAL CANCER CENTER HOSPITAL   (Japan)

^g ROSWELL PARK CANCER INSTITUTE   (United States)

^h UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

ⁱ MAYO CLINIC   (United States)

^j TAUSSIG CANCER INSTITUTE   (United States)

^k STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^l WEILL CORNELL MEDICAL COLLEGE   (United States)

^m WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Bronchiolitis obliterans syndrome; Chronic graft versus host disease; Cutaneous sclerosis; Graft versus host disease syndromes; Hematopoietic cell transplantation; Late acute graft versus host disease

Indexed keywords

CALCINEURIN INHIBITOR; METHOTREXATE; MYCOPHENOLATE MOFETIL; RAPAMYCIN; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOID LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BRONCHIOLITIS OBLITERANS; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; COHORT ANALYSIS; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT RECIPIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NONHODGKIN LYMPHOMA; NONMYELOABLATIVE CONDITIONING; PATIENT MONITORING; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROSPECTIVE STUDY; RECURRENCE FREE SURVIVAL; REDUCED INTENSITY CONDITIONING; SCLERODERMA; ACUTE DISEASE; ALLOGRAFT; CHRONIC DISEASE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MIDDLE AGED; SURVIVAL RATE;

ACUTE DISEASE; ADULT; AGED; ALLOGRAFTS; BRONCHIOLITIS OBLITERANS; CHRONIC DISEASE; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; SURVIVAL RATE;

EID: 84970015943     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2015.10.018     Document Type: Article

References (22)

1. 1 Fraser, C.J., Bhatia, S., Ness, K., et al. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study. Blood 108 (2006), 2867–2873.
2. 2 Socié, G., Stone, J.V., Wingard, J.R., et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 341 (1999), 14–21.
3. 3 Filipovich, A.H., Weisdorf, D., Pavletic, S., et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease, I: Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 11 (2005), 945–956.
4. 4 Jagasia, M.H., Greinix, H.T., Arora, M., et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease, I: 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 21 (2015), 389–401.
5. 5 Gooley, T.A., Leisenring, W., Crowley, J., Storer, B.E., Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18 (1999), 695–706.
6. 6 Kaplan, E.L., Meier, P., Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958), 457–481.
7. 7 Holtan, S.G., DeFor, T.E., Lazaryan, A., et al. Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation. Blood 125 (2015), 1333–1338.
8. 8 Cox, D.R., Regression models and life-tables. J R Stat Soc B 34 (1972), 187–220.
9. 9 Aisa, Y., Mori, T., Kato, J., et al. Validation of NIH consensus criteria for diagnosis and severity-grading of chronic graft-versus-host disease. Int J Hematol 97 (2013), 263–271.
10. 10 Arora, M., Nagaraj, S., Witte, J., et al. New classification of chronic GVHD: added clarity from the consensus diagnoses. Bone Marrow Transplant 43 (2009), 149–153.
11. 11 Cho, B.S., Min, C.K., Eom, K.S., et al. Feasibility of NIH consensus criteria for chronic graft-versus-host disease. Leukemia 23 (2009), 78–84.
12. 12 Jagasia, M., Giglia, J., Chinratanalab, W., et al. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria. Biol Blood Marrow Transplant 13 (2007), 1207–1215.
13. 13 Vigorito, A.C., Campregher, P.V., Storer, B.E., et al. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. Blood 114 (2009), 702–708.
14. 14 Lee, S.J., Vogelsang, G., Flowers, M.E., Chronic graft-versus-host disease. Biol Blood Marrow Transplant 9 (2003), 215–233.
15. 15 Arai, S., Arora, M., Wang, T., et al. Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 21 (2015), 266–274.
16. 16 Palmer, J., Williams, K., Inamoto, Y., et al. Pulmonary symptoms measured by the National Institutes of Health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease. Biol Blood Marrow Transplant 20 (2014), 337–344.
17. 17 Chien, J.W., Duncan, S., Williams, K.M., Pavletic, S.Z., Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation: an increasingly recognized manifestation of chronic graft-versus-host disease. Biol Blood Marrow Transplant 16:1 Suppl (2010), S106–114.
18. 18 Au, B.K., Au, M.A., Chien, J.W., Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 17 (2011), 1072–1078.
19. 19 Inamoto, Y., Storer, B.E., Petersdorf, E.W., et al. Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease. Blood 121 (2013), 5098–5103.
20. 20 Peñas, P.F., Jones-Caballero, M., Aragüés, M., et al. Sclerodermatous graft-vs-host disease: clinical and pathological study of 17 patients. Arch Dermatol 138 (2002), 924–934.
21. 21 Skert, C., Patriarca, F., Sperotto, A., et al. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome. Haematologica 91 (2006), 258–261.
22. 22 Chosidow, O., Bagot, M., Vernant, J.P., et al. Sclerodermatous chronic graft-versus-host disease: analysis of seven cases. J Am Acad Dermatol 26 (1992), 49–55.